United States Senate

Caucus on International Narcotics Control

 

Hearings

You are here

17 Nov

Drug Trafficking Across the Southwest Border and Oversight of U.S Counterdrug Assistance to Mexico

The Senate Caucus on International Narcotics Control (Drug Caucus) will hold a hearing on Tuesday, November 17, 2015 at 10:00 a.m. in SD-226 entitled “Drug Trafficking Across the Southwest Border and Oversight of U.S Counterdrug Assistance to Mexico.” 

Read More
24 Jun

Drug Caucus Hearing on Barriers to Cannabidiol Research

The hearing will address the complexities involved with conducting research on cannabidiol, a Schedule I substance, as well as its potential medical benefits and risks in treating serious illnesses such as intractable epilepsy.

Webcast starts at 18:45

Read More
05 May

Improving Management of the Controlled Substances Quota Process

The hearing explores the findings and recommendations of a recent Government Accountability Office report which highlights challenges with the Drug Enforcement Administration and the Food and Drug Administration’s  management the Controlled Substances quota process. 

Read More
14 May

Senate Caucus on International Narcotics Control hearing America’s Addiction to Opioids: Heroin and Prescription Drug Abuse

The hearing examined prescription drug abuse and the role it plays in the increased use of heroin in the United States, as well as how the federal government can help reduce opioid abuse.

Read More
14 Jan

Senate Caucus on International Narcotics Control Hearing on Future of U.S. Counternarcotics Efforts in Afghanistan

The hearing examined how the United States can sustain and improve counternarcotics efforts in Afghanistan as its military presence declines in 2014. The illegal drug trade is a contributing factor to many of the major challenges facing Afghanistan. Drug trafficking funds the Taliban, increases corruption and poses a serious public health challenge. 

Read More

Pages

United States Senate

Caucus on International Narcotics Control

Hart Senate Office Building
Room 517
Washington, D.C. 20510
Phone (202) 224-9032